CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 214 filers reported holding DENALI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,535,510
-36.6%
122,904
-9.3%
0.00%
-33.3%
Q2 2023$3,999,048
+40.0%
135,515
+9.3%
0.01%
+50.0%
Q1 2023$2,857,236
-13.4%
124,012
+4.6%
0.00%
-20.0%
Q4 2022$3,297,738
-4.9%
118,581
+5.0%
0.01%
-16.7%
Q3 2022$3,467,000
+2.5%
112,963
-1.7%
0.01%
+20.0%
Q2 2022$3,381,000
-1.4%
114,884
+7.8%
0.01%0.0%
Q1 2022$3,429,000
-34.0%
106,593
-8.5%
0.01%
-16.7%
Q4 2021$5,197,000
-9.4%
116,515
+2.4%
0.01%
-14.3%
Q3 2021$5,738,000
-41.7%
113,735
-9.3%
0.01%
-41.7%
Q2 2021$9,835,000
+81.6%
125,379
+32.2%
0.01%
+71.4%
Q1 2021$5,415,000
-32.1%
94,826
-0.4%
0.01%
-36.4%
Q4 2020$7,976,000
+133.8%
95,226
+0.0%
0.01%
+120.0%
Q3 2020$3,411,000
+48.8%
95,191
+0.4%
0.01%
+25.0%
Q2 2020$2,293,000
+65.2%
94,814
+19.6%
0.00%
+33.3%
Q1 2020$1,388,000
+9.6%
79,243
+9.0%
0.00%
+50.0%
Q4 2019$1,266,000
+10.6%
72,688
-2.7%
0.00%0.0%
Q3 2019$1,145,000
-25.3%
74,714
+1.2%
0.00%
-33.3%
Q2 2019$1,533,000
-6.1%
73,822
+5.0%
0.00%0.0%
Q1 2019$1,632,000
+8.3%
70,280
-3.7%
0.00%0.0%
Q4 2018$1,507,000
-0.6%
72,958
+4.7%
0.00%0.0%
Q3 2018$1,516,000
+283.8%
69,713
+169.5%
0.00%
+200.0%
Q2 2018$395,000
-18.4%
25,872
+5.3%
0.00%0.0%
Q1 2018$484,00024,5790.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Crestline Management, LP 7,460,732$240,012,00028.78%
Casdin Capital, LLC 1,500,000$48,255,0002.16%
Flagship Pioneering Inc. 2,619,968$84,284,0001.98%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 38,000$8,192,0001.85%
Yiheng Capital Management, L.P. 1,014,684$32,642,0001.49%
SECTORAL ASSET MANAGEMENT INC 207,100$6,662,0001.18%
Artal Group S.A. 600,000$19,302,0000.81%
GILDER GAGNON HOWE & CO LLC 2,619,217$84,260,0000.78%
Temasek Holdings (Private) Ltd 5,369,487$172,736,3970.73%
BRANDYWINE MANAGERS, LLC 9,601$309,0000.53%
View complete list of DENALI THERAPEUTICS INC shareholders